In our meta-analysis, we demonstrate that collagens, matrix metalloproteinases MMP2 and MMP9, immune system markers and markers in the TGFß signaling, and cardiac hypertrophy pathway are upregulated in anthracycline-induced cardiomyopathy whereas the AKT pro-survival pathway is downregulated. The gene discussed is MMP9; the disease is cardiac hypertrophy.